# Cannabis Company to Close Denver Grow Facility, Cutting 132 Jobs > **Author:** Benjamin Caplan, MD (ABFM Board Certified, MA Lic. #240562, NPI: 1962722637) > **Publisher:** CED Clinic (https://cedclinic.com) > **Canonical URL:** https://cedclinic.com/cannabis-industry-consolidation-impact-patient-access/ > **Published:** 2026-03-21T16:02:29-04:00 | **Last Modified / Clinically Audited:** 2026-09-28T10:42:22-04:00 > **Clinical Summary:** Explore the cannabis industry consolidation impact on patient access and supply chain disruptions affecting medical cannabis treatment continuity. --- ✦ New CED Clinical Relevance  #70Notable Clinical Interest  Emerging findings or policy developments worth monitoring closely. ⚒ Cannabis News  |  CED Clinic Supply Chain[Medical Cannabis](https://cedclinic.com/therapeutic-benefits-of-thc/)Patient AccessIndustryTreatment Continuity Why This Matters [Cannabis industry](https://cedclinic.com/cannabis-mold-contamination-risks-recall-safety/) consolidation and facility closures can disrupt patient access to consistent products, particularly for [medical cannabis](https://cedclinic.com/therapeutic-benefits-of-thc/) patients who rely on specific strains or formulations. Supply chain instability affects clinical outcomes when patients must switch between products with different cannabinoid profiles or potencies. Clinical Summary A cannabis company is closing its Denver cultivation facility, eliminating 132 jobs in what appears to reflect broader industry consolidation pressures. While specific company details weren’t provided, such closures typically result from oversupply, regulatory costs, or market saturation. For medical patients, facility closures can mean reduced product availability, potential price fluctuations, and forced transitions between different cannabis products that may have varying therapeutic profiles. Dr. Caplan’s Take “Industry instability directly impacts my patients’ treatment continuity — when their specific product disappears from shelves, we’re back to square one with dosing and efficacy. I tell patients to always have backup options identified before they need them.” Clinical Perspective 🧠 Clinicians should counsel cannabis patients about supply chain risks and help them identify alternative products with similar cannabinoid profiles before shortages occur. Patients benefit from understanding that [cannabis medicine](https://cedclinic.com/essential-oils-industrial-hemp-antimicrobial-benefits/) requires flexibility and backup planning, unlike traditional pharmaceuticals with more stable supply chains. 💬 Join the Conversation Have a question about how this applies to your situation? [Ask Dr. Caplan →](https://benjamincaplan.com/ask-dr-caplan) Want to discuss this topic with other patients and caregivers? [Join the forum discussion →](https://cedclinic.com/interact/discussion-forums/forum/cannabis-industry/) Have thoughts on this? Share it: [𝕏 Share on X](https://twitter.com/intent/tweet?text=Just%20read%20this%20on%20CEDclinic.com%3A%20Cannabis%20company%20to%20close%20Denver%20grow%20facility%2C%20cut%20132%20jobs%20-%20The%20Business%20Jour...%20%40drcaplan&url=https%3A//www.bizjournals.com/denver/news/2026/03/20/cannabis-company-cuts-132-jobs-closing-denver-grow.html)[in Share on LinkedIn](https://www.linkedin.com/sharing/share-offsite/?url=https%3A//www.bizjournals.com/denver/news/2026/03/20/cannabis-company-cuts-132-jobs-closing-denver-grow.html)[🦥 Share on BlueSky](https://bsky.app/intent/compose?text=Just%20read%20this%3A%20Cannabis%20company%20to%20close%20Denver%20grow%20facility%2C%20cut%20132%20jobs%20-%20The%20Business%20Jour...%20--%20via%20%40drcaplan.bsky.social%20https%3A//www.bizjournals.com/denver/news/2026/03/20/cannabis-company-cuts-132-jobs-closing-denver-grow.html)[📷 Follow on Instagram](https://www.instagram.com/drbenjamincaplan/)[📝 Read more on Substack](https://substack.com/@doctorapproved)[🔔 Subscribe via RSS](https://cedclinic.com/category/cannabis-news/feed/) 📰 Source: [https://www.bizjournals.com/denver/news/2026/03/20/cannabis-company-cuts-132-jobs-closing-denver-grow.html](https://www.bizjournals.com/denver/news/2026/03/20/cannabis-company-cuts-132-jobs-closing-denver-grow.html) Table of Contents - [FAQ](#FAQ)[What is the clinical relevance level of this cannabis news?](#What_is_the_clinical_relevance_level_of_this_cannabis_news) - [What are the main topics covered in this cannabis industry update?](#What_are_the_main_topics_covered_in_this_cannabis_industry_update) - [Why is this news categorized as having “Notable Clinical Interest”?](#Why_is_this_news_categorized_as_having_8220Notable_Clinical_Interest8221) - [How does this relate to patient access to medical cannabis?](#How_does_this_relate_to_patient_access_to_medical_cannabis) - [What should healthcare professionals know about these cannabis industry developments?](#What_should_healthcare_professionals_know_about_these_cannabis_industry_developments) - [Related](#Related) ## FAQ #### What is the clinical relevance level of this cannabis news? This article has been assigned a Clinical Relevance rating of #70, indicating “Notable Clinical Interest.” This means the findings or developments are emerging and worth monitoring closely by healthcare professionals. #### What are the main topics covered in this cannabis industry update? The article focuses on four key areas: supply chain issues, medical cannabis developments, patient access concerns, and broader industry trends. These topics are interconnected and impact the overall medical cannabis landscape. #### Why is this news categorized as having “Notable Clinical Interest”? The designation suggests this involves emerging findings or policy developments that could impact clinical practice. Healthcare providers should stay informed about these developments as they may affect [patient care](https://cedclinic.com/cannabis-cardiovascular-risk-impact/) and treatment options. #### How does this relate to patient access to medical cannabis? Patient access is identified as one of the key focus areas in this update. Supply chain and industry developments directly impact how easily patients can obtain prescribed [medical cannabis products](https://cedclinic.com/cannabis-infused-products-skin-diy-topical-recipes/). #### What should healthcare professionals know about these cannabis industry developments? Medical professionals should monitor these developments as they represent emerging trends that could influence treatment availability and protocols. The clinical relevance rating indicates these changes warrant professional attention and potential consideration in practice decisions. {“@context”: “https://schema.org”, “@type”: “NewsArticle”, “headline”: “Cannabis company to close Denver grow facility, cut 132 jobs – The Business Journals”, “url”: “https://www.bizjournals.com/denver/news/2026/03/20/cannabis-company-cuts-132-jobs-closing-denver-grow.html”, “datePublished”: “2026-03-21T16:15:56Z”, “about”: “cannabis company close denver grow facility”} [https://cedclinic.com/contact/](https://cedclinic.com/contact/) Physician-Led, Whole-Person Care A doctor who takes the time to truly understand you. Personal care that starts with listening and is guided by experience and ingenuity. Health, Longevity, Wellness One-on-One Cannabis Guidance Metabolic Balance [Leave a Message](https://cedclinic.com/contact/) [Metabolic Care](https://cedclinic.com/metabolic/metabolic-how-it-works/) [Medical Consulting](https://cedclinic.com/book/) [Cannabis Care](https://cedclinic.com/book/) [https://cedclinic.com/contact/](https://cedclinic.com/contact/) RELATED READING AT CED CLINIC Continue exploring the evidence [US (CO): Cannabis company to close Denver grow facility, cut 132 jobs](https://cedclinic.com/cannabis-industry-consolidation-impacts-denver-grow-facility/) Detailed report on the Denver cannabis facility closure and its implications for the local industry and workforce. [Read More](https://cedclinic.com/cannabis-industry-consolidation-impacts-denver-grow-facility/) [PharmaCann closing Denver cannabis grow facility, laying off 132 – The Denver Post](https://cedclinic.com/cannabis-industry-consolidation-trends-patient-access/) Coverage of PharmaCann's exit from the Colorado market and the resulting job cuts in the cannabis sector. [Learn More](https://cedclinic.com/cannabis-industry-consolidation-trends-patient-access/) Mass layoff as cannabis MSO PharmaCann exits Colorado market – MJBizDaily Analysis of the mass layoffs following PharmaCann's market exit and its impact on Colorado's [cannabis industry](https://cedclinic.com/cannabis-mold-contamination-risks-recall-safety/). Explore Article ### Related --- ### Verification & Medical Governance - **Lead Clinical Author:** Benjamin Caplan, MD - **Credentials:** Board Certified in Family Medicine (ABFM), Former CMO Canna Care Docs (250,000+ patients supervised), Founder & CMO CED Clinic & CED Foundation, Author of *The Doctor-Approved Cannabis Handbook* (Penguin Random House). - **Clinical Scale:** 350,000+ lifetime evaluations overseen; 81,008-patient Real-World Evidence Registry (`~/.ced_rwe_vault.db`); 125,000+ peer-reviewed study literature observatory (`http://localhost:8768/api/explorer/terminal`). - **License Verification:** Commonwealth of Massachusetts License #240562 (https://checkahealthlicense.mass.gov/). - **NPI Registry:** 1962722637 (https://npiregistry.cms.hhs.gov/provider-view/1962722637). - **Ethics & Data Privacy:** Clinical registry observations adhere strictly to HIPAA Safe Harbor de-identification (45 CFR § 164.514(b)) and criteria for secondary research exemption under 45 CFR § 46.104(d)(4).